Page
%P
-
Article
Open AccessAXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
AXL is a well-characterized, protumorigenic receptor tyrosine kinase that is highly expressed and activated in numerous human carcinomas and sarcomas, including aggressive subtypes of liposarcoma. However, the...